奎尔在酒引起的肝脏铁过载中对费里丁的保护作用
You Jin1, Hong-Mei Zeng2, Chan Peng3
1National Demonstration Center for Experimental Basic Medical Education, Huazhong University of Science and Technology, Wuhan, 430030, China.
Current medical science
|September 19, 2025
概括
奎尔丁治疗和铁限制通过改善铁过载和维持铁性来缓解酒精诱导的肝损伤. 这种天然化合物通过调节FOXO1-TFEB NCOA4通路中的关键蛋白质来防止肝损伤.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 营养生物化学 营养生物化学
- 细胞生物学 细胞生物学
背景情况:
- 慢性饮酒导致铁过载,加剧肝损伤.
- 酒精诱导的肝病的机制,包括费里丁和奎尔素的作用,尚未完全理解.
研究的目的:
- 调查奎尔丁对酒精诱导的肝损伤的保护作用.
- 阐明铁代谢和铁代谢在酒精性肝病的发病过程中的作用.
主要方法:
- 成年雄性小鼠在12周内被食含有乙醇的饮食,并使用奎尔或铁操纵.
- 在体外研究中使用乙醇化HepG2细胞与药理学剂和基因调节.
- 分析了肝损伤,铁沉积以及关键蛋白质表达 (p62,NCOA4,LC3-II,FOXO1).
主要成果:
- 乙醇食增加了肝损伤标志物和脂质积累,这些部分因瑞丁或铁限制而逆转.
- 奎尔赛丁降低了铁沉积和调节了参与费里丁 (NCOA4,LC3-II) 和FOXO1信号传递的蛋白质.
- 这些影响与铁含量和FOXO1-TFEB-NCOA4通路有关.
结论:
- 奎尔可以缓解酒精引起的肝损伤和二次铁过载.
- 保护机制涉及通过FOXO1-TFEB-NCOA4通路维持费里丁流和溶酶体功能.
- 铁代谢在酒精性肝病的进展中起着关键作用.
相关概念视频
EDTA: Chemistry and Properties
Polydentate ligands are most widely used in complexometric titrations because they form more stable complexes with the metal ions than mono- or bidentate ligands due to the chelate effect. Examples of polydentate ligands are ethylenediaminetetraacetic acid (EDTA), crown ethers, and cryptands. The most important feature of optimal polydentate ligands is the ability to form 1:1 complexes in a single-step process. Amino carboxylic acid derivatives are frequently used as complexing agents. EDTA is...
EDTA: Auxiliary Complexing Reagents
EDTA titrations are usually carried out in highly basic conditions, where the fully deprotonated form of EDTA, Y4−, actively complexes with the free metal ions in the solution. Several metal ions precipitate as hydrous oxide (hydroxides, oxides, or oxyhydroxides) under these conditions, lowering the concentration of free metal ions in the solution. For this reason, auxiliary complexing agents or ligands such as ammonia, tartrate, citrate, or triethanolamine are used in EDTA titrations to...
Liver Physiology
The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can also...
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can also...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Drug toxicity: Drug–Drug Interaction
Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
Hepatic Encephalopathy
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...


